Booster interval and age updated

The U.S. Food and Drug Administration (FDA) and CDC authorizing the use of a Pfizer-BioNTech & Moderna COVID-19 Vaccine to shorten the time between the completion of a primary series of the 2 vaccines and a booster dose to at least 5 months after completion of the primary vaccination series for individuals 12 years of age and older for Pfizer vaccine and and 18 years of age and older for Moderna vaccine. 

The booster interval recommendation for people who received the J&J vaccine is for 2 months for individuals 18 years of age and older.

A third primary series dose for certain immunocompromised children

CDC & FDA is also recommending that moderately or severely immunocompromised 5–11-year-olds receive an additional primary dose of vaccine 28 days after their second shot. At this time, only the Pfizer-BioNTech COVID-19 vaccine is authorized and recommended for children aged 5-11.

Doctors Liked to Read More